Microneedles for painless transdermal immunotherapeutic applications
Immunotherapy has recently garnered plenty of attention to improve the clinical outcomes in
the treatment of various diseases. However, owing to the dynamic nature of the immune …
the treatment of various diseases. However, owing to the dynamic nature of the immune …
Revisiting T ype 2‐high and T ype 2‐low airway inflammation in asthma: current knowledge and therapeutic implications
D Robinson, M Humbert, R Buhl… - Clinical & …, 2017 - Wiley Online Library
Asthma is a complex respiratory disorder characterized by marked heterogeneity in
individual patient disease triggers and response to therapy. Several asthma phenotypes …
individual patient disease triggers and response to therapy. Several asthma phenotypes …
[HTML][HTML] Metabolism meets immunity: The role of free fatty acid receptors in the immune system
E Alvarez-Curto, G Milligan - Biochemical pharmacology, 2016 - Elsevier
There are significant numbers of nutrient sensing G protein-coupled receptors (GPCRs) that
can be found in cells of the immune system and in tissues that are involved in metabolic …
can be found in cells of the immune system and in tissues that are involved in metabolic …
Regulation of type 2 innate lymphoid cell–dependent airway hyperreactivity by butyrate
Background Allergic asthma is characterized by airway hyperreactivity (AHR) and
inflammation driven by aberrant TH 2 responses. Type 2 innate lymphoid cells (ILC2s) are a …
inflammation driven by aberrant TH 2 responses. Type 2 innate lymphoid cells (ILC2s) are a …
[HTML][HTML] Long-term safety and efficacy of reslizumab in patients with eosinophilic asthma
K Murphy, J Jacobs, L Bjermer, JM Fahrenholz… - The Journal of Allergy …, 2017 - Elsevier
Background In placebo-controlled trials, reslizumab, an anti-IL-5 monoclonal antibody,
significantly reduced asthma exacerbations and improved lung function and asthma control …
significantly reduced asthma exacerbations and improved lung function and asthma control …
Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma
X Sun, T Hou, E Cheung, TNT Iu, VWH Tam… - Cellular & molecular …, 2020 - nature.com
We elucidated the anti-inflammatory mechanisms of IL-38 in allergic asthma. Human
bronchial epithelial cells and eosinophils were cocultured upon stimulation with the viral …
bronchial epithelial cells and eosinophils were cocultured upon stimulation with the viral …
Chromosome 17q21 genes ORMDL3 and GSDMB in asthma and immune diseases
Chromosome 17q21 contains a cluster of genes including ORMDL3 and GSDMB, which
have been highly linked to asthma in genome-wide association studies. ORMDL3 is …
have been highly linked to asthma in genome-wide association studies. ORMDL3 is …
IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease
JF Højen, MLV Kristensen, AS McKee, MT Wade… - Nature …, 2019 - nature.com
Abstract Interleukin (IL)-1R3 is the co-receptor in three signaling pathways that involve six
cytokines of the IL-1 family (IL-1α, IL-1β, IL-33, IL-36α, IL-36β and IL-36γ). In many diseases …
cytokines of the IL-1 family (IL-1α, IL-1β, IL-33, IL-36α, IL-36β and IL-36γ). In many diseases …
Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate‐to‐severe asthma
M Chen, K Shepard, M Yang, P Raut… - Clinical & …, 2021 - Wiley Online Library
Background Current biologic therapies target allergic, eosinophilic or type 2 inflammation
phenotypic asthma. However, frequency and degree of overlap among these subtypes is …
phenotypic asthma. However, frequency and degree of overlap among these subtypes is …
[HTML][HTML] Anti-inflammatory and analgesic potential of leaf extract of Justicia adhatoda L.(Acanthaceae) in Carrageenan and Formalin-induced models by targeting …
Plants are regarded as a valuable and inexpensive source of new drug development, and a
variety of plant compounds are now being used in clinical trials to treat a variety of ailments …
variety of plant compounds are now being used in clinical trials to treat a variety of ailments …